BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, December 13, 2025
Home
»
Newsletters
» BioWorld
BioWorld
April 7, 2000
View Archived Issues
Ista Registers For IPO Seeking $86M For Diabetic Drug Vitrase
Read More
Sangamo IPO Brings In $52M, Less Than Originally Sought
Read More
Other News To Note
Read More
Gilead And EyeTech In $32M Deal For Eye Disease Drug
Read More
Financings Raise $82M For Cubist, $56M For Ribozyme
Read More
With Single Genome Finished, Celera Genomics Stock Soars
Read More
Triangles Anti-HIV Drug Trial To Be Halted, Delaying NDA
Read More
Surprising Synthetic Pathway Discloses Potential Drugs For African Trypanosomiasis Cure
Read More
